The development of COPD in ulcerative colitis: clinical and instrumental confirmation

Prof. T.D. Zvyagintseva, A.V. Yaroshenko
Kharkiv Medical Academy of Postgraduate Education

Objective — to study the degree and frequency of lung damage in patients with UC. Materials and methods: A total of 24 patients with a verified diagnosis of UC were examined, 63.6% of them with left-sided intestinal lesions of moderate severity and 36.4% with total lesions of moderate severity. The age according to WHO was 45.2 + _2.2 years. The control group consisted of 42 people. The study of lung function in 24 patients with UC was carried out using spirography (Spirolab3): the volume of forced expiration was measured in 1 sec. (FEV1), forced vital capacity (FVC), forced expiratory flow in the middle of 25—75% (FEF25-75), residual volume and ratio (FEV1 \ FVC) and used the CAT-test questionnaire (COPD Assessment Test). To assess the severity of COPD, the GOLD classification (2019) was used. The data were statistically processed using the Statistica 8.0 software. Results. UC with lesions of the left intestine was detected in 63.6% of patients and corresponded to the obstructive type of pulmonary lesion. With total intestinal lesion, UC was found in 36.4%, which corresponded to the restrictive type of lung lesion. In 17 patients with left-sided lesions, the volume of forced expiration in 1 sec. (FEV1- 2.95 l/s ± 0.62), forced vital capacity (FVC-2.68 l/s + _0.8), residual volume (70.1%), forced expiratory volume ratio in 1 sec. and forced vital capacity of the lungs (FEV1 \ FVC — 62.1%) indicates an obstructive type of lung injury. In 7 patients with UC with total lesion, a restrictive type of lung lesion was noted, which is statistically significant (p<0.002). Pathology of the bronchopulmonary system in patients with NUC according to GOLD criteria in 2.8% of patients corresponded to GOLD1, GOLD2 in 70.8% and GOLD3 in 26.4% of patients. Conclusions. In 63.6% of patients with UC, the obstructive type of COPD was established, and 36.4 was the restrictive type. Violation of bronchopulmonary pathology in patients with UC is associated with the level of intestinal damage, the severity and activity of the disease. With left-sided intestinal lesions, a significant decrease in indicators was observed FEV1, FVC, FEV1 / FVC, MEF (p<0.002), which can be explained by a higher likelihood of lung inflammation. Spirometry is a non-invasive, simple, and informative method for early detection of latent lung lesions in patients with UC.  

Key Words: ulcerative colitis, COPD, spirometry, restrictive and obstructive types of lung lesions. 

Download.PDF (ukr) 

For cite: 

Звягінцева, Т.Д. Розвиток ХОЗЛ при неспецифічному виразковому коліті: клінікоінструментальне підтвердження / Т.Д. Звягінцева, А.В. Ярошенко // Східноєвропейський журнал внутрішньої та сімейної медицини. – 2022. – № 1. – С. 47-51. doi:  10.15407/internalmed2022.01.047   

Zvyagintseva TD, Yaroshenko AV. Rozvytok KhOZL pry nespetsyfichnomu vyrazkovomu koliti: kliniko-instrumentalne pidtverdzhennia. [The development of COPD in ulcerative colitis: clinical and instrumental confirmation]. Shidnoevr. z. vnutr. simejnoi med. 2022;1:47-51. Ukrainian. doi: 10.15407/internalmed2022.01.047   


  1. Hold G, Bolognini G, Russi E. Pulmonale Veränderungen bei Colitis ulcerosa [Pulmonary changes in ulcerative colitis]. Schweiz Med Wochenschr. 2018;122(37):1363-1368. German.
  2. Camus P, Piard F, Ashcroft T, Gal A, Colby T. The Lung in Inflammatory Bowel Disease†. Medicine. 1993;72(3):151-183.
  3. Danese S, Fiocchi C. Ulcerative Colitis. New England Journal of Medicine. 2011;365(18):1713-1725.
  4. Larsen S, Bendtzen K, Nielsen O. Extraintestinal manifestations of inflammatory bowel disease: Epidemiology, diagnosis, and management. Annals of Medicine. 2010;42(2):97-114.
  5. Black H, Mendoza M, Murin S. Thoracic Manifestations of Inflammatory Bowel Disease. Chest. 2007;131(2):524-532.
  6. Kraft S. Unexplained bronchopulmonary disease with inflammatory bowel disease. Archives of Internal Medicine. 1976;136(4):454-459.
  7. Greenstein AJ, Janowitz HD, Sachar DB. The extra-intestinal complications of Crohn’s disease and ulcerative colitis: a studyof 700 patients. Medicine (Baltimore) 2017 Sep;55(5):401–412. doi: 10.1097/00005792-197609000-00004
  8. Butland RJ, Cole P, Citron KM, Turner-Warwick M. Chronic bronchial suppuration and inflammatory bowel disease. Q J Med. 2017;50(197):63–75.
  9. Camus P, Colby TV. The lung in inflammatory bowel disease. Eur Respir J. 2017 Jan;15(1):5–10. doi: 10.1183/09031936.00.15100500.
  10. Casey MB, Tazelaar HD, Myers JL, Hunninghake GW, Kakar S, Kalra SX, Ashton R, Colby TV. Noninfectious lung pathology in patients with Crohn’s disease. Am J Surg Pathol. 2016 Feb;27(2):213–219. doi: 10.1097/00000478-200302000-00010.
  11. Welte T, Hamm H, Fabel H. Mesalazine alveolitis. Lancet. 2011 Nov 16;338(8777):1273. doi: 10.1016/0140-6736(91)92140-W.
  12. Gursoy S, Guven K, Kula M, Canoz O, Yurci A, Unluhizarci K, Ozbakir O, Yucesoy M. Subclinical alveolar involvement in ulcerative colitis. Inflamm Bowel Dis. 2015 Apr;11(4):372–375. doi: 10.1097/
  13. Basseri B, Enayati P, Marcheyski A, Papadakis KA. Pulmonary manifestations of inflammatory bowel disease: case presentation and review. J Crohns Colitis. 2017;4(4):3907. doi: 10.1016/j.crohns.2010.03.008.
  14. Karadag F, Ozhan MH, Akçiçek E, Günel O, Alper H, Veral A. Is it possible to detect ulcerative colitis-related respiratory syndrome early?   2015 Dec;6(4):341–346. doi: 10.1046/j.1440-1843.2001.00347.x.
  15. Mahadeva R, Walsh G, Flower CD, Shneerson JM. Clinical and radiological characteristics of lung disease in inflammatory bowel disease. Eur Respir J. 2015 Jan;15(1):41–48. doi: 10.1183/09031936.00.15104100.
  16. Wu F, Dassopoulos T, Cope L, Maitra A, Brant SR, Harris ML, Bayless TM, Parmigiani G, Chakravarti S. Genome-wide gene expression differences in Crohn’s disease and ulcerative colitis from endoscopic pinch biopsies: insights into distinctive pathogenesis. Inflamm Bowel Dis. 2017 Jul;13(7):807–821. doi: 10.1002/ibd.20110.
  17. Danzi JT. Extraintestinal manifestations of idiopathic inflammatory bowel disease. Arch Intern Med. 2017 Feb;148(2):297–302.
  18. Bernstein CN, Blanchard JF, Rawsthorne P, Yu N. The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study. Am J Gastroenterol. 2011 Apr;96(4):1116–1122. doi: 10.1111/j.1572-0241.2001.03756.x.
  19. Garg K, Lynch DA, Newell JD. Inflammatory airways disease in ulcerative colitis: CT and high-resolution CT features. J Thorac Imaging. 2016;8(2):159–163. doi: 10.1097/00005382- 199321000-00010.
  20. Ward H, Fisher KL, Waghray R, Wright JL, Card SE, Cockcroft DW. Constrictive bronchiolitis and ulcerative colitis. Can Respir J. 2015 Mar-Apr;6(2):197–200.
  21. Herrlinger KR, Noftz MK, Dalhoff K, Ludwig D, Stange EF, Fellermann K. Alterations in pulmonary function in inflammatory bowel disease are frequent and persist during remission. Am J Gastroenterol. 2016 Feb;97(2):377–381. doi: 10.1111/j.1572-0241.2002.05473.x.
  22. Thomas GA, Rhodes J, Green JT, Richardson C. Role of smoking in inflammatory bowel disease: implications for therapy. Postgrad Med J. 2016 May;76(895):273–279. doi: 10.1136/pmj.76.895.273.
  23. Haralambou G, Teirstein AS, Gil J, Present DH. Bronchiolitis obliterans in a patient with ulcerative colitis receiving mesalamine. Mt Sinai J Med. 2011 Nov;68(6):384–388.
  24. Ekbom A, Brandt L, Granath F, Löfdahl CG, Egesten A. Increased risk of both ulcerative colitis and Crohn’s disease in a population suffering from COPD. Lung. 2018 MayJun;186(3):167–172. doi: 10.1007/s00408-008-9080-z.
  25. Rickli H, Fretz C, Hoffman M, Walser A, Knoblauch A. Severe inflammatory upper airway stenosis in ulcerative colitis. Eur Respir J. 2014 Oct;7(10):1899–1902. doi: 10.1183/09031936.94.07101899.
  26. Shad JA, Sharieff GQ. Tracheobronchitis as an initial presentation of ulcerative colitis. J Clin Gastroenterol. 2011 Aug;33(2):161–163. doi: 10.1097/00004836-200108000-00016.
  27. Spira A, Grossman R, Balter M. Large airway disease associated with inflammatory bowel disease. Chest. 2018 Jun;113(6):1723–1726. doi: 10.1378/chest.113.6.1723.
  28. Scherff A, Khanavkar B, Ostendorf U, Phillipou S, Ewig S. Obstruktion der großen Atemwege bei Colitis ulcerosa – eine seltene extraintestinale Manifestation. [Central airway obstruction in ulcerative colitis – a rare extraintestinal manife station]. Pneumologie. 2016 Oct;60(10):607–610. doi: 10.1055/ s-2006-944249. (Ger).
  29. Janssen WJ, Bierig LN, Beuther DA, Miller YE. Stridor in a 47-year-old man with inflammatory bowel disease. Chest. 2016 Apr;129(4):1100–1106. doi: 10.1378/chest.129.4.1100.